EULAR® 2024 Insights
EULAR® 2024 Insights - Challenging the Difficult-to-Treat Rheumatoid Arthritis: Comparative Analysis of Clinical Efficacy and Drug Retention of Subsequent Biologic and Targeted Synthetic Disease-modifying Anti-rheumatic Drugs
By
EULAR® 2024 Insights
FEATURING
Ladislav Šenolt
By
EULAR® 2024 Insights
FEATURING
Ladislav Šenolt
Login to view comments.
Click here to Login
